Viatris Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Viatris Inc with three other
companies in this sector in UNITED STATES :
sales of $6.68 billion
of which 53%
Regeneron Pharmaceuticals Incorporated
of which 58%
was EYLEA), and
Vertex Pharmaceuticals Inc
of which 62%
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Viatris Inc totalled
an increase of 67.6%
from the $2.73 billion in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled $9.01 billion, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Viatris Inc were $11.95 billion.
increase of 3.9%
versus 2019, when the company's sales were $11.50 billion.